Angela I Schriek
Overview
Explore the profile of Angela I Schriek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grobben M, Bakker M, Schriek A, Levels L, Umotoy J, Tejjani K, et al.
PLoS Pathog
. 2024 Dec;
20(12):e1012739.
PMID: 39661636
HIV-1 infection leads to chronic disease requiring life-long treatment and therefore alternative therapeutics, a cure and/or a protective vaccine are needed. Antibody-mediated effector functions could have a role in the...
2.
de Taeye S, Faye L, Morel B, Schriek A, Umotoy J, Yuan M, et al.
Plant Biotechnol J
. 2024 Nov;
23(1):4-16.
PMID: 39563066
Prevention of severe COVID-19 disease by SARS-CoV-2 in high-risk patients, such as immuno-compromised individuals, can be achieved by administration of antibody prophylaxis, but producing antibodies can be costly. Plant expression...
3.
Umotoy J, Kroon P, Man S, van Dort K, Atabey T, Schriek A, et al.
iScience
. 2024 Oct;
27(10):110958.
PMID: 39391729
HIV-1 alters the dynamics and distribution of tetraspanins, a group of proteins integral to membrane organization, to facilitate both entry and egress. Notably, the tetraspanin CD9 is dysregulated during HIV-1...
4.
Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions
Schriek A, Falck D, Wuhrer M, Kootstra N, van Gils M, de Taeye S
Antiviral Res
. 2024 Sep;
231:106015.
PMID: 39343065
Substantial reduction of the intact proviral reservoir is essential towards HIV-1 cure. In vivo administration of broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) trimer can decrease the...
5.
van der Straten K, Guerra D, Kerster G, Claireaux M, Grobben M, Schriek A, et al.
PLoS Pathog
. 2024 Aug;
20(8):e1012453.
PMID: 39146376
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by human sera is a strong correlate of protection against symptomatic and severe Coronavirus Disease 2019 (COVID-19). The emergence of antigenically...
6.
de Taeye S, Schriek A, Umotoy J, Grobben M, Burger J, Sanders R, et al.
Commun Biol
. 2024 Aug;
7(1):964.
PMID: 39122901
Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To...
7.
Anbuhl S, Dervillez X, Neubacher S, Schriek A, Bobkov V, de Taeye S, et al.
Biochem Pharmacol
. 2024 Aug;
227:116457.
PMID: 39098732
The chemokine receptor CXCR4 is involved in the development and migration of stem and immune cells but is also implicated in tumor progression and metastasis for a variety of cancers....
8.
Radic L, Sliepen K, Yin V, Brinkkemper M, Capella-Pujol J, Schriek A, et al.
iScience
. 2023 Apr;
26(4):106540.
PMID: 37063468
SARS-CoV-2 variants evade current monoclonal antibody therapies. Bispecific antibodies (bsAbs) combine the specificities of two distinct antibodies taking advantage of the avidity and synergy provided by targeting different epitopes. Here...
9.
Koers J, Sciarrillo R, Derksen N, Vletter E, Fillie-Grijpma Y, Raveling-Eelsing E, et al.
J Allergy Clin Immunol
. 2023 Jan;
151(6):1646-1654.
PMID: 36716825
Background: Increased prevalence of autoantibody Fab glycosylation has been demonstrated for several autoimmune diseases. Objectives: To study whether elevated Fab glycosylation is a common feature of autoimmunity, this study investigated...
10.
Schriek A, van Haaren M, Poniman M, Dekkers G, Bentlage A, Grobben M, et al.
Front Immunol
. 2022 Dec;
13:1091668.
PMID: 36483568
[This corrects the article DOI: 10.3389/fimmu.2022.893648.].